CLINICAL_TRIALS ClinicalTrials.gov record update

A Safety Trial of Lisocabtagene Maraleucel (JCAR017) for Relapsed and Refractory (R/R) B-cell Non-Hodgkin Lymphoma (NHL) in the Outpatient Setting

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03744676
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:26:48.404089+00:00
Published At: 2023-12-06T00:00:00+00:00
Record Updated At: 2025-02-27
Results Posted At: 2023-12-06
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Lymphoma, Non-Hodgkin", "Lymphoma", "Lymphoma, B-Cell", "Lymphoma, Large B-Cell, Diffuse", "Neoplasms", "Neoplasms by Histologic Type", "Lymphoproliferative Disorders", "Lymphatic Diseases", "Immunoproliferative Disorders", "Immune System Disorder"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-02-27"
protocolSection.identificationModule.nctId: "NCT03744676"
protocolSection.identificationModule.officialTitle: "A Safety Trial of Lisocabtagene Maraleucel (JCAR017) for Relapsed and Refractory (R/R) B-cell Non-Hodgkin Lymphoma (NHL) in the Outpatient Setting"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2023-12-06"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.